Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Professor/ Consultant Surgeon

Clinical Research And Teaching · Nigeria · 2025-06-12

Processing Time
398 days
Decision Date
2025-06-12
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his work in clinical research and teaching, specifically focusing on harnessing next-generation sequencing and molecular tumor profiling to improve early cancer detection. His work aims to develop targeted therapies for populations historically underrepresented in precision medicine, such as those of African descent.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses systemic inequities in medical research and aligns with the White House Cancer Moonshot initiative.

2 Well-positioned to Advance the Endeavor Met

The petitioner has decades of experience, 55 publications, and over 680 citations, demonstrating a track record of success.

3 Balance of Interests Met

The urgent need for equitable cancer therapies and the petitioner's unique expertise in African-descent genomics make a waiver of labor certification beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's 55 peer-reviewed publications and over 680 citations, 95% of which were independent. He demonstrated significant impact through 12 peer reviews for international journals and funding from prestigious agencies like the NIH Fogarty International Center and HRSA. The case successfully satisfied all three Dhanasar prongs after a comprehensive RFE response.

Request for Evidence (RFE)

Successfully Addressed

The RFE was anticipated due to a strategic 1-page initial filing to protect a child's CSPA status. The response included detailed evidence of leadership, publication metrics, and alignment with national health initiatives.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance the EndeavorBalance of Interests

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Government Alignment
Original Contributions
Judging Experience

Similar Cases

Research Scientist

Information Technology · India

WeGreened EB-2 (NIW) approved
Texas 46 days 2025-06-09
The petitioner proposes to develop advanced computational algorithms to analyze genomic data for identifying mutations and variants that drive cancer progression. This work involves prioritizing and validating cancer driver genes and integrating these findings into clinical workflows to improve diagnosis accuracy and prognosis. The goal is to support personalized treatment strategies and reduce the impact of cancer on patients and the U.S. healthcare system.
View Case

Data Scientist

Biotechnology

WeGreened EB-2 (NIW) approved
71 days 2025-01-04
The petitioner proposes to interrogate multimodal genomic and clinical datasets from cancer patients to uncover key associations between genetic traits, clinical features, and therapeutic responses. This work aims to enable the development of individualized cancer treatment strategies and reduce the financial and human burden of cancer in the U.S.
View Case

Others

Biotechnology · India

WeGreened EB-2 (NIW) approved
195 days 2022-05-06
The petitioner proposes to continue developing genomic screening platforms and gene therapy-based approaches to facilitate the design of novel treatment modalities for cancer. This work focuses on identifying genetic factors that contribute to cancer development and progression using state-of-the-art molecular methods.
View Case

Others

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 464 days 2022-05-21
The petitioner proposes to continue the full characterization of cellular and genetic mechanisms related to cancers that interact with their surrounding microenvironment. The work focuses on improving treatment strategies, identifying therapeutic targets to slow metastasis, and mitigating the economic costs associated with cancer care.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Nigeria

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-12.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 398 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nigeria All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist